These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 28913963)

  • 1. Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0.
    Wang SV; Schneeweiss S; Berger ML; Brown J; de Vries F; Douglas I; Gagne JJ; Gini R; Klungel O; Mullins CD; Nguyen MD; Rassen JA; Smeeth L; Sturkenboom M;
    Pharmacoepidemiol Drug Saf; 2017 Sep; 26(9):1018-1032. PubMed ID: 28913963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0.
    Wang SV; Schneeweiss S; Berger ML; Brown J; de Vries F; Douglas I; Gagne JJ; Gini R; Klungel O; Mullins CD; Nguyen MD; Rassen JA; Smeeth L; Sturkenboom M;
    Value Health; 2017 Sep; 20(8):1009-1022. PubMed ID: 28964431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transparency and Reproducibility of Observational Cohort Studies Using Large Healthcare Databases.
    Wang SV; Verpillat P; Rassen JA; Patrick A; Garry EM; Bartels DB
    Clin Pharmacol Ther; 2016 Mar; 99(3):325-32. PubMed ID: 26690726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reproducibility of real-world evidence studies using clinical practice data to inform regulatory and coverage decisions.
    Wang SV; Sreedhara SK; Schneeweiss S;
    Nat Commun; 2022 Aug; 13(1):5126. PubMed ID: 36045130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-controlled designs in pharmacoepidemiology involving electronic healthcare databases: a systematic review.
    Gault N; Castañeda-Sanabria J; De Rycke Y; Guillo S; Foulon S; Tubach F
    BMC Med Res Methodol; 2017 Feb; 17(1):25. PubMed ID: 28178924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HARmonized Protocol Template to Enhance Reproducibility of hypothesis evaluating real-world evidence studies on treatment effects: A good practices report of a joint ISPE/ISPOR task force.
    Wang SV; Pottegård A; Crown W; Arlett P; Ashcroft DM; Benchimol EI; Berger ML; Crane G; Goettsch W; Hua W; Kabadi S; Kern DM; Kurz X; Langan S; Nonaka T; Orsini L; Perez-Gutthann S; Pinheiro S; Pratt N; Schneeweiss S; Toussi M; Williams RJ
    Pharmacoepidemiol Drug Saf; 2023 Jan; 32(1):44-55. PubMed ID: 36215113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healthcare Databases for Drug Safety Research: Data Validity Assessment Remains Crucial.
    Rawson NSB; D'Arcy C
    Drug Saf; 2018 Sep; 41(9):829-833. PubMed ID: 29714003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Table 0; documenting the steps to go from clinical database to research dataset.
    de Kok JWTM; van Bussel BCT; Schnabel R; van Herpt TTW; Driessen RGH; Meijs DAM; Goossens JA; Mertens HJMM; van Kuijk SMJ; Wynants L; van der Horst ICC; van Rosmalen F
    J Clin Epidemiol; 2024 Jun; 170():111342. PubMed ID: 38574979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HARmonized Protocol Template to Enhance Reproducibility of Hypothesis Evaluating Real-World Evidence Studies on Treatment Effects: A Good Practices Report of a Joint ISPE/ISPOR Task Force.
    Wang SV; Pottegård A; Crown W; Arlett P; Ashcroft DM; Benchimol EI; Berger ML; Crane G; Goettsch W; Hua W; Kabadi S; Kern DM; Kurz X; Langan S; Nonaka T; Orsini L; Perez-Gutthann S; Pinheiro S; Pratt N; Schneeweiss S; Toussi M; Williams RJ
    Value Health; 2022 Oct; 25(10):1663-1672. PubMed ID: 36241338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reliability and validity assessment of administrative databases in measuring the quality of rectal cancer management.
    Corbellini C; Andreoni B; Ansaloni L; Sgroi G; Martinotti M; Scandroglio I; Carzaniga P; Longoni M; Foschi D; Dionigi P; Morandi E; Agnello M;
    Tumori; 2018; 104(1):51-59. PubMed ID: 29218691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transparency, reproducibility, and replicability of pharmacoepidemiology studies in a distributed network environment.
    Rai A; Maro JC; Dutcher S; Bright P; Toh S
    Pharmacoepidemiol Drug Saf; 2024 Jun; 33(6):e5820. PubMed ID: 38783407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Systematic Review of Coding Systems Used in Pharmacoepidemiology and Database Research.
    Chen Y; Zivkovic M; Wang T; Su S; Lee J; Bortnichak EA
    Methods Inf Med; 2018 Feb; 57(1):1-42. PubMed ID: 29621836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving Transparency to Build Trust in Real-World Secondary Data Studies for Hypothesis Testing-Why, What, and How: Recommendations and a Road Map from the Real-World Evidence Transparency Initiative.
    Orsini LS; Berger M; Crown W; Daniel G; Eichler HG; Goettsch W; Graff J; Guerino J; Jonsson P; Lederer NM; Monz B; Mullins CD; Schneeweiss S; Brunt DV; Wang SV; Willke RJ
    Value Health; 2020 Sep; 23(9):1128-1136. PubMed ID: 32940229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Healthcare Databases in Thailand and Japan: Potential Sources for Health Technology Assessment Research.
    Saokaew S; Sugimoto T; Kamae I; Pratoomsoot C; Chaiyakunapruk N
    PLoS One; 2015; 10(11):e0141993. PubMed ID: 26560127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of real-world evidence for healthcare decision-making in the Middle East: practical considerations and future directions.
    Akhras KS; Alsheikh-Ali AA; Kabbani S
    Expert Rev Pharmacoecon Outcomes Res; 2019 Jun; 19(3):245-250. PubMed ID: 30626231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Describing diversity of real world data sources in pharmacoepidemiologic studies: The DIVERSE scoping review.
    Gini R; Pajouheshnia R; Gardarsdottir H; Bennett D; Li L; Gulea C; Wientzek-Fleischmann A; Bazelier MT; Burcu M; Dodd C; Durán CE; Kaplan S; Lanes S; Marinier K; Roberto G; Soman K; Zhou X; Platt R; Setoguchi S; Hall GC
    Pharmacoepidemiol Drug Saf; 2024 May; 33(5):e5787. PubMed ID: 38724471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electronic healthcare databases in Europe: descriptive analysis of characteristics and potential for use in medicines regulation.
    Pacurariu A; Plueschke K; McGettigan P; Morales DR; Slattery J; Vogl D; Goedecke T; Kurz X; Cave A
    BMJ Open; 2018 Sep; 8(9):e023090. PubMed ID: 30185579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-world reproducibility study characterizing patients newly diagnosed with multiple myeloma using Clinical Practice Research Datalink, a UK-based electronic health records database.
    Seesaghur A; Petruski-Ivleva N; Banks V; Wang JR; Mattox P; Hoeben E; Maskell J; Neasham D; Reynolds SL; Kafatos G
    Pharmacoepidemiol Drug Saf; 2021 Feb; 30(2):248-256. PubMed ID: 33174338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving transparency to build trust in real-world secondary data studies for hypothesis testing-Why, what, and how: recommendations and a road map from the real-world evidence transparency initiative.
    Orsini LS; Monz B; Mullins CD; Van Brunt D; Daniel G; Eichler HG; Graff J; Guerino J; Berger M; Lederer NM; Jonsson P; Schneeweiss S; Wang SV; Crown W; Goettsch W; Willke RJ
    Pharmacoepidemiol Drug Saf; 2020 Nov; 29(11):1504-1513. PubMed ID: 32924243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.